DAILY SUAREZ ROQUE: Open Payments
NPI 1619476306 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,027 in 43 payments from 11 companies in 2025. Trend: 2023 $1,014 · 2024 $1,175 · 2025 $1,027
Food & beverage: $1,027
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $321 |
| GlaxoSmithKline, LLC. | 8 | $192 |
| Sumitomo Pharma America, Inc. | 9 | $189 |
| Novo Nordisk Inc | 7 | $147 |
| PFIZER INC. | 2 | $43 |
| Averitas Pharma Inc. | 1 | $31 |
| Exact Sciences Corporation | 1 | $28 |
| Amgen Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $21 |
| Lilly USA, LLC | 1 | $21 |
Products named: FARXIGA, TRELEGY ELLIPTA, GEMTESA, BREZTRI, Ozempic, Rybelsus, QUTENZA, AIRSUPRA.
Industry payments across FL — which companies pay providers there.
